The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Adaptive data-driven age and patch mixing in contact networks with recurrent mobility

    1. Jesse Knight
    2. Huiting Ma
    3. Amir Ghasemi
    4. Mackenzie Hamilton
    5. Kevin Brown
    6. Sharmistha Mishra

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. ViralFlow: A Versatile Automated Workflow for SARS-CoV-2 Genome Assembly, Lineage Assignment, Mutations and Intrahost Variant Detection

    1. Filipe Zimmer Dezordi
    2. Antonio Marinho da Silva Neto
    3. Túlio de Lima Campos
    4. Pedro Miguel Carneiro Jeronimo
    5. Cleber Furtado Aksenen
    6. Suzana Porto Almeida
    7. Gabriel Luz Wallau
    8. on behalf of the Fiocruz COVID-19 Genomic Surveillance Network

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. The Importance of Semantic Network Brain Regions in Integrating Prior Knowledge with an Ongoing Dialogue

    1. Petar P. Raykov
    2. James L. Keidel
    3. Jane Oakhill
    4. Chris M. Bird

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. “Epidemiological profile of patients with stage 5 chronic kidney disease on dialysis with Covid 19 infection in a Public Hospital-Perú”

    1. Yanissa Venegas-Justiniano
    2. César Loza-Munarriz
    3. Abdías Hurtado-Aréstegui

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom

    1. Matilde Otero-Losada
    2. Nikolai Petrovsky
    3. Abdallah Alami
    4. James A. Crispo
    5. Donald Mattison
    6. Francisco Capani
    7. Christopher Goetz
    8. Daniel Krewski
    9. Santiago Perez-Lloret

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

    1. Simeon Schietzel
    2. Manuel Anderegg
    3. Andreas Limacher
    4. Alexander Born
    5. Michael P Horn
    6. Britta Maurer
    7. Cedric Hirzel
    8. Daniel Sidler
    9. Matthias B Moor

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Mini-XT, a miniaturized tagmentation-based protocol for efficient sequencing of SARS-CoV-2

    1. Marc Fuchs
    2. Clara Radulescu
    3. Miao Tang
    4. Arun Mahesh
    5. Deborah Lavin
    6. Syed Umbreen
    7. James McKenna
    8. Mark Smyth
    9. Eilís McColgan
    10. Zoltan Molnar
    11. Chris Baxter
    12. Timofey Skvortsov
    13. Aditi Singh
    14. Fiona Rogan
    15. Julia Miskelly
    16. Stephen Bridgett
    17. Derek Fairley
    18. David A. Simpson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients

    1. Kin Wah Fung
    2. Seo H. Baik
    3. Fitsum Baye
    4. Zhaonian Zheng
    5. Vojtech Huser
    6. Clement J. McDonald

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations

    1. Elizabeth M. Anderson
    2. Shuk Hang Li
    3. Moses Awofolaju
    4. Theresa Eilola
    5. Eileen Goodwin
    6. Marcus J. Bolton
    7. Sigrid Gouma
    8. Tomaz B. Manzoni
    9. Philip Hicks
    10. Rishi R. Goel
    11. Mark M. Painter
    12. Sokratis A. Apostolidis
    13. Divij Mathew
    14. Debora Dunbar
    15. Danielle Fiore
    16. Amanda Brock
    17. JoEllen Weaver
    18. John S. Millar
    19. Stephanie DerOhannessian
    20. Allison R. Greenplate
    21. Ian Frank
    22. Daniel J. Rader
    23. E. John Wherry
    24. Paul Bates
    25. Scott E. Hensley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

    1. Laurence Chu
    2. Keith Vrbicky
    3. David Montefiori
    4. Wenmei Huang
    5. Biliana Nestorova
    6. Ying Chang
    7. Andrea Carfi
    8. Darin K. Edwards
    9. Judy Oestreicher
    10. Holly Legault
    11. Frank J. Dutko
    12. Bethany Girard
    13. Rolando Pajon
    14. Jacqueline M. Miller
    15. Rituparna Das
    16. Brett Leav
    17. Roderick McPhee

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 906 of 2361 Older